ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,639, issued on Nov. 11, was assigned to Replimune Ltd. GB (Oxfordshire, Great Britain).
"Modified oncolytic virus" was invented by Robert Stuart Coffin (London).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an oncolytic virus comprising: (i) a fusogenic protein-encoding gene and (ii) an immune stimulatory molecule-encoding gene."
The patent was filed on Sept. 6, 2023, under Application No. 18/462,133.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=...